AH
Therapeutic Areas
IDL Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| UBC Rapid | Bladder Cancer Monitoring | Commercial |
| TK 210 ELISA | Cancer Therapy Monitoring (e.g., Breast Cancer) | Commercial / Clinical Development |
| Drug | Indication | Phase |
|---|---|---|
| UBC Rapid | Bladder Cancer Monitoring | Commercial |
| TK 210 ELISA | Cancer Therapy Monitoring (e.g., Breast Cancer) | Commercial / Clinical Development |